Immunotherapy of Equine Sarcoids-From Early Approaches to Innovative Vaccines
Christoph Jindra University of Veterinary Medicine Vienna / Karl Landsteiner University of Health Sciences
University of Veterinary Medicine Vienna
University of Veterinary Medicine Vienna
MDPI
Horses and other equid species are frequently affected by bovine papillomavirus type 1 and/or 2 (BPV1, BPV2)-induced skin tumors termed sarcoids. Although sarcoids do not metastasize, they constitute a serious health problem due to their BPV1/2-mediated resistance to treatment and propensity to recrudesce in a more severe, multiple form following accidental or iatrogenic trauma. This review provides an overview on BPV1/2 infection and associated immune escape in the equid host and presents early and recent immunotherapeutic approaches in sarcoid management.
Englisch
2023
Dieses Werk bzw. dieser Inhalt steht unter einer
CC BY 4.0 - Creative Commons Namensnennung 4.0 International Lizenz.
CC BY 4.0 International
http://creativecommons.org/licenses/by/4.0/
Bovine Papillomavirus Type-1; Virus-Like Particles; Regulatory T-Cell; Leukocyte Antigens; Tumor-Cells; Human Interleukin-2; Immune-Response; Gene-Expression; Dna; Protein